April 14th 2025
Furthermore, C-reactive protein has greater prognosis for lung cancer, colorectal cancer, and ovarian cancer.
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
The Oncology Pharmacist’s Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enh...
August 12, 2025 | 6:00 PM ET & 8:00 PM ET
View More
Overcoming Disparities in Multiple Myeloma Treatment: Empowering Pharmacists to Drive Change
1.0 Credit / Health Equity, Diversity & Inclusion, Hematologic Cancer, Hematology, Oncology
View More
An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities...
1.5 Credits / Breast Cancer, Oncology
View More
Navigating Treatment Evolution in Myelofibrosis: Oncology Pharmacist's Strategies for JAK Inhibitor Optimizati...
1.0 Credit / Hematologic Cancer, Hematology, Oncology
View More
Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Phar...
September 10, 2025 | 1:00 PM ET & 8:00 PM ET
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatme...
1.0 Credit / Hematologic Cancer, Oncology
View More
The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non‒Small Cell Lung Cancer
0.5 Credit / Oncology, Lung Cancer
View More
Transforming Small Cell Lung Cancer Management With DLL3-Targeted Therapies
1.0 Credit / Oncology, Lung Cancer
View More
Cytokine Release Syndrome With Bispecific Antibodies: A Pharmacist's Guide to Safe Management
1.0 Credit / Hematologic Cancer, Lung Cancer, Oncology
View More
A Pharmacist's Guide to the Safe and Effective Management of BTK and BCL-2 inhibitors in Chronic Lymphocytic L...
1.0 Credit / Hematologic Cancer, Oncology
View More
How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists
1.0 Credit / Oncology
View More
Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events
1.0 Credit / Oncology
View More
Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity ...
1.0 Credit / Gynecologic Cancer, Oncology, Women's Health
View More
Closing Gaps in CLL Care: Managed Care Insights and Strategies
1.5 Credit / Hematologic Cancer, Oncology
View More
Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Anti...
1.0 Credit / Oncology
View More
Advancements in Extensive-Stage Small Cell Lung Cancer Therapy: Integrating Clinical Evidence to Fill Gaps in ...
1.0 Credit / Oncology, Lung Cancer
View More
Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care
1.5 Credits / Hematologic Cancer, Hematology, Oncology
View More
Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations
1.0 Credit / Hematologic Cancer, Oncology
View More
ASH Annual Meeting Coverage: Highlighting the Recent Updates in TKI Use in the Treatment of CML – Insights and...
1.0 Credit / Oncology, Hematology, Hematologic Cancer
View More
Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma
1.5 Credits / Hematologic Cancer, Oncology, Hematology
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based R...
1.5 Credits / Hematologic Cancer, Hematology, Oncology
View More
Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management
1.5 Credits / Oncology, Hematology
View More
Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer
1.5 Credits / Breast Cancer, Oncology, Women's Health
View More
Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma
1.0 Credits / Oncology
View More
Tracking a Moving Target in HR+ Metastatic Breast Cancer: Innovative Oral Therapies and Evolving Strategies
1.0 Credits / Oncology
View More
An Evolving Treatment Paradigm: Innovative Approaches and Critical Insights in the Management of Newly Diagnos...
1.0 Credits / Oncology
View More
Advancing Care in Metastatic Prostate Cancer Care: Emerging Combination Therapies and Patient-Centered Strateg...
1.0 Credits / Oncology
View More
CVD Risk in Type 2 Diabetes May Be Impacted by GnRH Agonists for Prostate Cancer
August 10th 2022New research suggests there was a 53% greater 5-year risk of cardiovascular disease in men with type 2 diabetes who received a GnRH agonist for prostate cancer compared with their counterparts who did not receive GnRH agonists.
Ensuring Equitable Access to Therapeutic Advances in Oncology
February 14th 2022Jenny Sherak, president of Specialty Physician Services at AmerisourceBergen sat down with Drug Topics® to discuss how her team provides the best customer experiences for community oncology practices across the United States.
Targeted Drug Combination Reveals New Activity in Brain Tumors
December 28th 2021A combination of two targeted cancer drugs showed unprecedented, “clinically meaningful” activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.
Priority Review Granted to Toripalimab by FDA for Nasopharyngeal Carcinoma
November 2nd 2021The FDA has accepted for review a biologics license application for the use of toripalimab in combination with gemcitabine and cisplatin in the frontline treatment of patients with advanced recurrent or metastatic nasopharyngeal carcinoma.